drugset / Trial / NCT02807974
Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria
NaSingle-groupOpen-labelTreatment
Summary
To examine antihypertensive effect and safety of administration of CS-3150 in combination with ARB or ACE inhibitor in hypertensive patients with type 2 diabetes and albuminuria.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CS-3150 | Unknown | 1.25 mg | Oral |
| Subject | CS-3150 | Unknown | 2.5 mg | Oral |
| Subject | CS-3150 | Unknown | 5 mg | Oral |